First Manhattan CO Brainstorm Cell Therapeutics Inc. Transaction History

First Manhattan CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$3.99 - $17.73 $13,965 - $62,055	-3,500 Reduced 87.5%	500 $2,000
Q3 2019 Nov 13, 2019	BUY	$3.54 - $4.48 $1,770 - $2,240	500 Added 14.29%	4,000 $15,000
Q3 2017 Oct 25, 2017	BUY	$3.98 - $4.36 $13,930 - $15,260	3,500	3,500 $14,000

10.8M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $83.2M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.